Recent HRTX Stock Price | HRTX Stock Predictions | |
$2.71 | +158.30% |
$7.00 |
Recent HRTX Analyst Ratings Breakdown, Making HRTX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 2 | 2 | 2 | 3 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.33 | 1.33 | 1.33 | 1.25 |
For the HRTX stock predictions from the analysts covering Heron Therapeutics Inc, we have collected all of the individual HRTX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering HRTX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since HRTX stock predictions may vary widely, another useful metric to consider is the median HRTX stock prediction, which represents the price at which half of the analysts
made HRTX stock predictions that were higher and half made HRTX stock predictions that were lower. This makes for a different take on the HRTX stock predictions out there, as compared to average or mean.
And that median across all the individual HRTX stock predictions was: $7.0 as of 2024-04-19.
The very highest of the HRTX stock predictions for one year price target was $9.0, while the very lowest of the HRTX stock predictions in the analyst group was
$5.0 (with a standard deviation of $2.0). Get the latest Zacks research report on HRTX — FREE
Find out: HRTX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
REGI Stock Predictions
CELC Stock Predictions
DAVA Stock Predictions
XEL Stock Predictions
CLPR Stock Predictions
SMTC Stock Predictions
DMRC Stock Predictions
SLF Stock Predictions
FVRR Stock Predictions
|
|
Strong Buy (3.67 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |